Complement 3 (C3) and 4 (C4) levels and anti-double-stranded DNA antibody (anti-dsDNA Ab) were considered efficient and conventional biomarkers of active lupus and were components of SLEDAI. The gene discussed is C4A; the disease is systemic lupus erythematosus.